Director Dealing

Summary by AI BETAClose X

4basebio PLC announced that its Chief Executive Officer, Dr. Amy Walker, purchased 1,863 ordinary shares on the market for 509.00 pence per share on May 21, 2026. This transaction increases her shareholding to 48,529 ordinary shares, representing 0.31% of the Company's issued share capital, which comprises 15,538,518 ordinary shares. The purchase of these shares, representing approximately 0.01% of the issued share capital, indicates confidence from the CEO in the company's prospects.

Disclaimer*

Companies

4basebio (4BB)
UK 100

Latest directors dealings